2026 Vincenzo Sorrentino: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	69	7531	6945	189	182	221	14397

Overview

Vincenzo Sorrentino is affiliated with the University of Siena in Italy. Their research activity spans multiple topics within the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. The primary subfields of study include Molecular Biology, Cardiology and Cardiovascular Medicine, Physiology, Cellular and Molecular Neuroscience, and Cell Biology.

Their work addresses a variety of main topics, including:

Ion channel regulation and function
Cardiomyopathy and Myosin Studies
Muscle Physiology and Disorders
Ion Channels and Receptors
RNA Research and Splicing
Cellular transport and secretion
Cardiac electrophysiology and arrhythmias

Vincenzo Sorrentino has frequently published in several venues, among which are:

The Journal of General Physiology
International Journal of Molecular Sciences
Journal of Muscle Research and Cell Motility
Scientific Reports
Journal of Cell Science

Frequent co-authors collaborating with Sorrentino include:

Daniela Rossi
Enrico Pierantozzi
Matteo Serano
Filip Van Petegem
Egidio Maria Rubino

Among recent papers authored or co-authored by Sorrentino are the following publications:

"Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases," published in 2020 in Cell Death and Disease
"The Sarcoplasmic Reticulum of Skeletal Muscle Cells: A Labyrinth of Membrane Contact Sites," published in 2022 in Biomolecules
"Calsequestrin, a key protein in striated muscle health and disease," published in 2020 in Journal of Muscle Research and Cell Motility
"Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies," published in 2022 in The Journal of General Physiology
"Ryanodine receptor 1 ( RYR1 ) mutations in two patients with tubular aggregate myopathy," published in 2022 in European Journal of Neuroscience

Best Publications

Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia

Silvia G. Priori;Carlo Napolitano;Natascia Tiso;Mirella Memmi

1649
Citations
The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

Giuseppe Giannini;Antonio Conti;Sandra Mammarella;Marina Scrobogna

662
Citations
Ryanodine receptors: how many, where and why?

Vincenzo Sorrentino;Pompeo Volpe

430
Citations
Expression of a ryanodine receptor-Ca2+ channel that is regulated by TGF-beta.

Giuseppe Giannini;Emilio Clementi;Roberta Ceci;Giovanna Marziali

300
Citations
MECP2 mutation in male patients with non-specific X-linked mental retardation

Alfredo Orrico;Ching-Wan Lam;Lucia Galli;Maria Teresa Dotti

296
Citations
Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.

V. Sorrentino;R. Pepperkok;R. L. Davis;W. Ansorge

271
Citations
Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development.

E M Coccia;C Cicala;A Charlesworth;C Ciccarelli

262
Citations
ras gene Amplification and malignant transformation.

S. Pulciani;E. Santos;L. K. Long;Vincenzo Sorrentino

219
Citations
Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles

Paola Bagnato;Virigina Barone;Emiliana Giacomello;Daniela Rossi

211
Citations
Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning

Detlef Balschun;David P. Wolfer;Federica Bertocchini;Virginia Barone

203
Citations
Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies

M. Kelliher;J. Fastbom;R. F. Cowburn;W. Bonkale

189
Citations
Pluripotency Regulators in Human Mesenchymal Stem Cells: Expression of NANOG But Not of OCT-4 and SOX-2

Enrico Pierantozzi;Barbara Gava;Ivana Manini;Franco Roviello

177
Citations
Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.

Federica Bertocchini;Catherine E. Ovitt;Antonio Conti;Virginia Barone

163
Citations
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes

C. G. Egan;R. Lavery;F. Caporali;C. Fondelli

155
Citations
Xestospongin C is an equally potent inhibitor of the inositol 1,4,5-trisphosphate receptor and the endoplasmic-reticulum Ca(2+) pumps.

P De Smet;Jb Parys;G Callewaert;Af Weidema

152
Citations
Differential distribution of ryanodine receptor type 3 (RyR3) gene product in mammalian skeletal muscles.

Antonio Conti;L. Gorza;Vincenzo Sorrentino

152
Citations
Regulation of Calcium Sparks and Spontaneous Transient Outward Currents by RyR3 in Arterial Vascular Smooth Muscle Cells

Matthias Löhn;Wolfgang Jessner;Michael Fürstenau;Maren Wellner

151
Citations
The E3 Ubiquitin Ligase IDOL Induces the Degradation of the Low Density Lipoprotein Receptor Family Members VLDLR and ApoER2

Cynthia Hong;Sarah Duit;Pilvi Jalonen;Ruud Out

149
Citations
Molecular genetics of ryanodine receptors Ca2+-release channels.

Daniela Rossi;Vincenzo Sorrentino

149
Citations
MECP2 mutation in male patients with non-speci¢c X-linked mental retardation

Alfredo Orrico;Ching-Wan Lam;Lucia Galli;Maria Teresa Dotti

0
Citations